Who invested in Holmusk

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & AnalyticsBiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$40Mraised across 2 rounds since 2018, from 2 sources

$9.8MSeries A$30MVenture

Latest round: Venture, $30MOct 2023
Step-upi: 3.1×
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20192020202120222023

$9.8MSeries A$30MVenture

First round: Series A, $9.8M
Biggest round: $30M
Between rounds: 5 years

The rounds

Oct 2023
Venture$30M2 new
- Novartis
- Optum Ventures
Source recordedSEC filing: $30M sold, first sale Sept 2023
Sept 2018
Series A$9.8M1 new
- Heritas Venture Fund
Reported by FinSMEs

Founders and team

From Holmusk's own website: 1 founder, 11 on the team.

Nawal RoyFounder & Director

Tony TramontinCEO & Director
Alex VanceChief Clinical Data Officer
Eileen Cheong YouneChief Product Officer
Eze AbosiChief Growth Officer
Sai SubramanianChief Technology Officer
Alex YevzelmanVP, Real-World Data
Samantha TomickiVP, Life Science Partnerships
Charles BooradyDirector
May LiewDirector
Michael WeintraubChair of the Board
Scientific AdvisorBoard of Directors

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2018Venture2023

Novartis

Optum VenturesHeritas Venture Fund

Everyone who backed them

NovartisVC firm1round

Optum VenturesVC firm1round

Heritas Venture Fundno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Holmusk as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.